Novo Nordisk
Options Smart Investment Report: Novo Nordisk's call order surges over 8 times; oral weight loss drug receives FDA approval.
I. Overview of US Stock Index Options Trading volume in the US stock index options market is currently declining, and t...
TPU gets straight to the finals! What did Google do right after ten years of developing this chip?
With the advent of Gemini 3, Google's TPU has moved from behind the scenes to the forefront. Nvidia The dominance o...
New Model Dominates Rankings: An Interview with Google Team – How a New AI Leader Emerges
On November 19th, the long-awaited and widely discussed Gemini 3 was finally officially unveiled. Google didn't jus...
The price of the weight-loss miracle drug has dropped from $1,350 per month to $350. The GLP-1 market will shift from a duopoly in the United States to multi-dimensional competition.
Recently, Eli Lilly and Nord Agreement reached with the US government on GLP-1 weight loss drug Significant price reduc...
Like a business war epic! The latest developments in the battle for the "rising star of weight-loss drugs" among industry giants are here!
[Introduction] Pfizer An amendment to the merger agreement with Metsera was reached, valuing Metsera at up to $86.25 pe...
Google's AI chip stock surges pre-market, signaling a major boost for the PCB industry.
According to CNBC, Google is rolling out its most powerful AI chip yet. Ironwood will be widely available in the coming...
Google's quarterly revenue surpasses $100 billion for the first time; capital expenditures expected to increase significantly next year.
Cloud business maintained high growth, driving tech giant Google's quarterly revenue to surpass $100 billion for th...
